Experiment 813431

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismMaytenus buchananii (CELASTRACEAE)
CitationCABANILLAS,F: RODRIGUEZ,V: HALL,SW: BURGESS,MA: BODEY,GP: FREIREICH,EJ:. (1978). PHASE 1 STUDY OF MAYTANSINE USING A 3-DAY SCHEDULE.. 62()
Amount utilized
Compound isolated
DiseaseTHIS WAS A PHASE I STUDY ALL PATIENTS WERE OVER AGE 15 AND HAD METASTATIC MALIGNANT DISEASE-108 COURSES OF DRUG WERE GIVEN DETERIORATION OF LIVER FUNCTION TESTS IN 3 PATIENTS WHO HAD ABNORMAL LIVER FUNCTION BEFORE TREATMENT MODERATE STOMATITIS AND MILD ALOPECIA IN 3 PATIENTS
Dose amount0.60 MG
Number3
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES